Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
<p>Suppl. Tables S1-S8</p>
Guardado en:
| Autor principal: | Gary N. Schwartz (16005870) (author) |
|---|---|
| Otros Autores: | Peter A. Kaufman (16005873) (author), Karthik V. Giridhar (16005876) (author), Jonathan D. Marotti (16005879) (author), Mary D. Chamberlin (15036341) (author), Bradley A. Arrick (16005882) (author), Grace Makari-Judson (16005885) (author), Matthew P. Goetz (8863130) (author), Shannon M. Soucy (16005888) (author), Fred Kolling (16005891) (author), Eugene Demidenko (16005894) (author), Todd W. Miller (16005897) (author) |
| Publicado: |
2025
|
| Materias: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Supplementary Figure 17 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
por: Biagio Ricciuti (14951247)
Publicado: (2025) -
Supplementary Figure S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
por: Arathi Mohan (15561346)
Publicado: (2025) -
Supplementary Table S4 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
por: Arathi Mohan (15561346)
Publicado: (2025) -
Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
por: Tom Wei-Wu Chen (15053003)
Publicado: (2025) -
Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
por: Tom Wei-Wu Chen (15053003)
Publicado: (2025)